pqq cofactor has been researched along with Cognitive Decline in 2 studies
PQQ Cofactor: A pyrrolo-quinoline having two adjacent keto-groups at the 4 and 5 positions and three acidic carboxyl groups. It is a coenzyme of some DEHYDROGENASES.
pyrroloquinoline quinone : A pyrroloquinoline having oxo groups at the 4- and 5-positions and carboxy groups at the 2-, 7- and 9-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "D-galactose (D-gal) has been considered a senescent model which induces oxidative stress response resulting in memory dysfunction." | 1.48 | PQQ ameliorates D-galactose induced cognitive impairments by reducing glutamate neurotoxicity via the GSK-3β/Akt signaling pathway in mouse. ( Mao, SS; Peng, Y; Qin, XF; Xu, D; Yao, ZW; Zhang, RJ; Zhou, XQ, 2018) |
| "Cognitive impairments were prevented and bioenergetic deficits partially reversed when Tg(+/-) rats were fed a nutritionally complete diet from weaning to 6-month-old supplemented with pyrroloquinoline quinone, a mitochondrial biogenesis stimulator with antioxidant and neuroprotective effects." | 1.46 | Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease. ( Cassina, A; Castaño, EM; Cuello, AC; Do Carmo, S; Evelson, P; Galeano, P; Leal, MC; Magnani, N; Martino Adami, PV; Morelli, L; Quijano, C, 2017) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, XQ | 1 |
| Yao, ZW | 1 |
| Peng, Y | 1 |
| Mao, SS | 1 |
| Xu, D | 1 |
| Qin, XF | 1 |
| Zhang, RJ | 1 |
| Martino Adami, PV | 1 |
| Quijano, C | 1 |
| Magnani, N | 1 |
| Galeano, P | 1 |
| Evelson, P | 1 |
| Cassina, A | 1 |
| Do Carmo, S | 1 |
| Leal, MC | 1 |
| Castaño, EM | 1 |
| Cuello, AC | 1 |
| Morelli, L | 1 |
2 other studies available for pqq cofactor and Cognitive Decline
| Article | Year |
|---|---|
PQQ ameliorates D-galactose induced cognitive impairments by reducing glutamate neurotoxicity via the GSK-3β/Akt signaling pathway in mouse.
Topics: Animals; Cognitive Dysfunction; Cytosol; Galactose; Glutamic Acid; Glycogen Synthase Kinase 3 beta; | 2018 |
Synaptosomal bioenergetic defects are associated with cognitive impairment in a transgenic rat model of early Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Cognitive Dysfunction; Diet Therapy; Disease Models, Animal; Electron Tr | 2017 |